AgomAb Therapeutics NV (AGMB)
7.76
-0.64
(-7.62%)
USD |
NASDAQ |
Oct 28, 16:00
8.11
+0.35
(+4.51%)
After-Hours: 19:46
AgomAb Therapeutics Price : 7.76 for Oct. 28, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 27, 2026 | 8.60 | 8.60 | 7.88 | 8.40 | 89798.00 |
| Oct 26, 2026 | 9.10 | 9.33 | 8.44 | 8.57 | 73851.00 |
| Oct 23, 2026 | 9.15 | 9.184 | 8.566 | 9.05 | 52224.00 |
| Oct 22, 2026 | 9.15 | 9.44 | 8.90 | 9.26 | 84323.00 |
| Oct 21, 2026 | 8.74 | 9.22 | 8.74 | 9.11 | 46836.00 |
| Oct 20, 2026 | 8.24 | 8.97 | 8.21 | 8.73 | 35303.00 |
| Oct 19, 2026 | 8.28 | 8.61 | 8.16 | 8.23 | 40376.00 |
| Oct 16, 2026 | 8.21 | 8.53 | 7.92 | 8.28 | 78133.00 |
| Oct 15, 2026 | 8.56 | 8.86 | 8.15 | 8.33 | 97715.00 |
| Oct 14, 2026 | 8.80 | 9.08 | 8.51 | 8.69 | 57697.00 |
| Oct 13, 2026 | 9.05 | 9.35 | 8.725 | 8.81 | 59376.00 |
| Oct 12, 2026 | 9.18 | 9.65 | 9.045 | 9.09 | 62284.00 |
| Oct 09, 2026 | 9.36 | 9.49 | 8.915 | 9.08 | 102315.0 |
| Oct 08, 2026 | 8.88 | 9.45 | 8.56 | 9.22 | 225189.0 |
| Oct 07, 2026 | 8.95 | 9.350 | 8.675 | 8.80 | 104931.0 |
| Oct 06, 2026 | 8.77 | 8.965 | 8.395 | 8.84 | 103921.0 |
| Oct 05, 2026 | 8.51 | 8.71 | 7.97 | 8.69 | 129804.0 |
| Oct 02, 2026 | 8.65 | 9.34 | 8.00 | 8.56 | 391631.0 |
| Oct 01, 2026 | 11.21 | 11.32 | 8.56 | 8.65 | 639377.0 |
| Sep 30, 2026 | 10.62 | 11.36 | 10.58 | 11.10 | 133706.0 |
| Sep 29, 2026 | 10.23 | 10.69 | 10.14 | 10.53 | 113492.0 |
| Sep 28, 2026 | 10.51 | 10.54 | 9.865 | 10.21 | 147156.0 |
| Sep 25, 2026 | 10.65 | 11.23 | 10.41 | 10.51 | 164026.0 |
| Sep 24, 2026 | 10.75 | 10.99 | 10.50 | 10.58 | 64174.00 |
| Sep 23, 2026 | 11.54 | 11.80 | 10.64 | 10.76 | 98687.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cocrystal Pharma, Inc. | 0.9999 |
| CNBX Pharmaceuticals, Inc. | 0.0001 |
| Invion Ltd. | 0.0369 |
| Arvinas, Inc. | 7.59 |
| Fulcrum Therapeutics, Inc. | 3.77 |
Price Related Metrics
| Market Cap | 382.16M |